Targeting DNA repair as a promising approach in cancer therapy
- 25 June 2007
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 43 (12), 1791-1801
- https://doi.org/10.1016/j.ejca.2007.05.003
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Hypersensitivity phenotypes associated with genetic and synthetic inhibitor-induced base excision repair deficiencyDNA Repair, 2007
- Cancer risks among BRCA1 and BRCA2 mutation carriersBritish Journal of Cancer, 2007
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2006
- The cellular control of DNA double‐strand breaksJournal of Cellular Biochemistry, 2006
- Drug development in oncology: classical cytotoxics and molecularly targeted agentsBritish Journal of Clinical Pharmacology, 2006
- The multifaceted mismatch-repair systemNature Reviews Molecular Cell Biology, 2006
- Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 2004
- Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell linesInternational Journal of Cancer, 2004
- Activity and unexpected lung toxicity of the sequential administration of two alkylating agents—Dacarbazine and fotemustine—in patients with melanomaEuropean Journal Of Cancer, 1993
- Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma—an effective combination with unexpected toxicityEuropean Journal Of Cancer, 1992